Receipt of cardiac screening does not influence 1-year post-cerebrovascular event mortality

dc.contributor.authorSico, Jason J.
dc.contributor.authorBaye, Fitsum
dc.contributor.authorMyers, Laura J.
dc.contributor.authorConcato, John
dc.contributor.authorFerguson, Jared
dc.contributor.authorCheng, Eric M.
dc.contributor.authorJadbabaie, Farid
dc.contributor.authorYu, Zhangsheng
dc.contributor.authorArling, Gregory
dc.contributor.authorZillich, Alan J.
dc.contributor.authorReeves, Matthew J.
dc.contributor.authorWilliams, Linda S.
dc.contributor.authorBravata, Dawn M.
dc.contributor.departmentBiostatistics, School of Public Healthen_US
dc.date.accessioned2019-05-09T20:29:29Z
dc.date.available2019-05-09T20:29:29Z
dc.date.issued2018-06
dc.description.abstractBackground: American Heart Association/American Stroke Association expert consensus guidelines recommend consideration of cardiac stress testing to screen for occult coronary heart disease (CHD) among patients with ischemic stroke/TIA who have a high-risk Framingham Cardiac Risk Score (FCRS). Whether this guideline is being implemented in routine clinical practice, and the association of its implementation with mortality, is less clear. Methods: Study participants were Veterans with stroke/TIA (n = 11,306) during fiscal year 2011 who presented to a VA Emergency Department or who were admitted. Patients were excluded (n = 6,915) based on prior CHD/angina/chest pain history, receipt of cardiac stress testing within 18 months prior to cerebrovascular event, death within 90 days of discharge, discharge to hospice, transfer to a non-VA acute care facility, or missing/unknown race. FCRS ≥20% was classified as high risk for CHD. ICD-9 and Common Procedural Terminology codes were used to identify receipt of any cardiac stress testing. Results: Among 4,391 eligible patients, 62.8% (n = 2,759) had FCRS ≥20%. Cardiac stress testing was performed infrequently and in similar proportion among high-risk (4.5% [123/2,759]) vs low/intermediate-risk (4.4% [72/1,632]) patients (adjusted odds ratio [aOR] 0.77, 95% confidence interval [CI] 0.54-1.10). Receipt of stress testing was not associated with reduced 1-year mortality (aOR 0.59, CI 0.26-1.30). Conclusions: In this observational cohort study of patients with cerebrovascular disease, cardiac screening was relatively uncommon and was not associated with 1-year mortality. Additional work is needed to understand the utility of CHD screening among high-risk patients with cerebrovascular disease.en_US
dc.identifier.citationSico, J. J., Baye, F., Myers, L. J., Concato, J., Ferguson, J., Cheng, E. M., … Bravata, D. M. (2018). Receipt of cardiac screening does not influence 1-year post-cerebrovascular event mortality. Neurology. Clinical practice, 8(3), 192–200. doi:10.1212/CPJ.0000000000000465en_US
dc.identifier.urihttps://hdl.handle.net/1805/19206
dc.language.isoen_USen_US
dc.publisherWolters Kluweren_US
dc.relation.isversionof10.1212/CPJ.0000000000000465en_US
dc.relation.journalNeurology: Clinical practiceen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.sourcePMCen_US
dc.subjectCardiac stress testingen_US
dc.subjectOccult coronary heart diseaseen_US
dc.subjectFramingham Cardiac Risk Scoreen_US
dc.subjectIschemic stroke/TIAen_US
dc.titleReceipt of cardiac screening does not influence 1-year post-cerebrovascular event mortalityen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
NEURCLINPRACT2017022319.pdf
Size:
201.52 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: